Navigation Links
Leading Biotoxin & Mold Illness Authority Creates Certification Process for Treatment Protocol
Date:3/29/2013

Pokomoke, MD (PRWEB) March 29, 2013

Dr. Ritchie Shoemaker, recognized leader in the field of biotoxin and mold illness, announced his retirement from active practice in January. However he continues to remain dedicated to mold illness patients and research by implementing a certification program for doctors who wish to treat their own patients with the protocol.

Referred to as the Shoemaker Protocol, it remains a leading treatment method for mold related illness, a debilitating and often misdiagnosed condition. According to Dr. Shoemaker, “This exam will allow docs to show their competence in the basic sciences and clinical management of illnesses associated with exposure to biotoxins.”

Dr. Shoemaker points out that this is not an online study course, but rather an opportunity for doctors to receive materials, training, testing, and certification administered directly from the physician that created the protocol. The certification testing is a three step process involves a screening exam, essay questions, and an oral exam.

“We are pleased with the interest in the program. To date, over 500 physicians have become involved. The number one question submitted to the website is ‘Is there a doctor in my area that can help me?’”, reports Dr. Shoemaker. “Finally, we will be able to provide an answer.”

Ritchie Shoemaker, M.D. is an internationally recognized leader in education, patient care, and research in the field of biotoxin related illness, and has treated over 6,000 patients. Dr. Shoemaker has written numerous papers and eight books, including the widely read Mold Warriors and Surviving Mold. He has appeared on Good Morning America, the BBC, the Australian Broadcasting System, the Discovery Health Channel, and has spoken to the House of Representatives and the US Senate. He continues to give lectures and attend conferences on biotoxin illness.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10581957.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
2. Leading Photonics and Laser Researchers to Present Latest Work at SPIE Optics + Optoelectronics
3. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
4. BioElectronics Product Cited for "Most Innovative New OTC Product" From Leading UK-based Healthcare Marketing Publication
5. Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
6. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
7. Mylan to Acquire Agila to Create Leading Global Injectables Platform
8. Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
9. Drogueria Americana, a Honduran Affiliate of GeneCell International, Presents to a Panel of More Than 100 Leading Dentist on Dental Pulp Stem Cells
10. Biotrial, a Leading Provider of Drug Development Services, Has Completed its Acquisition of Warnex Bioanalytical Services Division
11. Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
Breaking Biology Technology:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other or against ... (PRNewsFoto/Dermalog Identification Systems) ... Matching" is the fastest software for biometric Face Matching on the market. The ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
Breaking Biology News(10 mins):